Halo Pharmaceutical names new CEO

CDMO makes two key additions to management team

Halo Pharmaceutical, a rapidly growing contract development and manufacturing organisation (CDMO), has announced the appointments of Lee Karras as its Chief Executive Officer and Barry Lederman as its Chief Financial Officer.

Karras is an established pharmaceutical business executive with more than 25 years of healthcare industry related experience. Prior to joining Halo, he held executive leadership roles in several businesses, most recently as President of IBA Molecular North America, a global leader in the manufacture and distribution of radiopharmaceuticals.

Having worked in the contract pharmaceutical services industry over the last two decades, Karras has had to adapt and develop new business models to keep pace with the ever changing pharmaceutical landscape.

Lederman has extensive financial and international pharmaceutical experience, having led teams of several public and private companies with global operations. Prior to joining Halo, he served as the Vice President and CFO for Eisai Inc.